BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12483874)

  • 1. [Jansky-Bielschowsky disease].
    Saitoh S
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):252-4. PubMed ID: 12483874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kufs' disease].
    Nagasato K
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):258-61. PubMed ID: 12483876
    [No Abstract]   [Full Text] [Related]  

  • 3. Case 27-2002: late-onset infantile neuronal ceroid lipofuscinosis.
    McBride KL
    N Engl J Med; 2003 May; 348(21):2159. PubMed ID: 12761381
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neuronal ceroid lipofuscinosis (NCL, Batten's disease)].
    Ohno K
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):486-8. PubMed ID: 11032003
    [No Abstract]   [Full Text] [Related]  

  • 5. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
    Koul R; Al-Futaisi A; Ganesh A; Rangnath Bushnarmuth S
    J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal testing for late infantile neuronal ceroid lipofuscinosis.
    Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P
    Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation].
    Bukina AM; Tsvetkova IV; Semiachkina AN; Il'ina ES
    Vopr Med Khim; 2002; 48(6):594-8. PubMed ID: 12698559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spielmeyer-Vogt-Sjögren disease].
    Saitoh S
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):255-7. PubMed ID: 12483875
    [No Abstract]   [Full Text] [Related]  

  • 9. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene.
    Hartikainen JM; Ju W; Wisniewski KE; Moroziewicz DN; Kaczmarski AL; McLendon L; Zhong D; Suarez CT; Brown WT; Zhong N
    Mol Genet Metab; 1999 Jun; 67(2):162-8. PubMed ID: 10356316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal ceroid lipofuscinosis/Batten disease: the lysosomal proteinoses.
    Gupta P; Hofmann SL
    Mol Psychiatry; 2002; 7(5):434-6. PubMed ID: 12082556
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuronal ceroid lipofuscinosis: late infantile or Jansky Bielschowsky type--re-revisited.
    Wheeler RB; Schlie M; Kominami E; Gerhard L; Goebel HH
    Acta Neuropathol; 2001 Nov; 102(5):485-8. PubMed ID: 11699562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
    Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
    Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nonsense mutation (Q509X) in three Italian late-infantile neuronal ceroid-lipofuscinosis children.
    Tessa A; Simonati A; Tavoni A; Bertini E; Santorelli FM
    Hum Mutat; 2000 Jun; 15(6):577. PubMed ID: 10862088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusion of late infantile neuronal ceroid lipofuscinosis (LINCL) in a fetus by assay of tripeptidyl peptidase I in chorionic villi.
    Young EP; Winchester BG; Peter Logan W; Wheeler RB; Lake BD
    Prenat Diagn; 2000 Apr; 20(4):337-9. PubMed ID: 10740208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays.
    Sohar I; Lin L; Lobel P
    Clin Chem; 2000 Jul; 46(7):1005-8. PubMed ID: 10894849
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations.
    Steinfeld R; Heim P; von Gregory H; Meyer K; Ullrich K; Goebel HH; Kohlschütter A
    Am J Med Genet; 2002 Nov; 112(4):347-54. PubMed ID: 12376936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
    Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
    Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis.
    Barisić N; Logan P; Pikija S; Skarpa D; Blau N
    Croat Med J; 2003 Aug; 44(4):489-93. PubMed ID: 12950156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.
    Chattopadhyay S; Pearce DA
    Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.